RayVio’s Portable and Versatile Ultraviolet Technology Protects against Germs in Water, Air and On Surfaces
The sun’s rays provide warmth and light that enhance your general feeling of well-being and stimulate blood circulation. Some UV radiation is essential to the body as it stimulates the production of vitamin D. UV radiation has been used to successfully treat a number of diseases, including rickets, psoriasis, eczema, and jaundice.
The growing prevalence of infectious viruses and diseases ranging from H1N1 to Ebola to measles is a threat that impacts everyone. Whether on a plane, on a subway, or at a restaurant, the risk of contracting a potentially fatal virus or disease is an increasingly realistic and serious threat.
RayVio Applications (Image credit: RayVio)
UV light is widely used to protect against germs in water, surfaces, and air, and can also aid in treating skin diseases including psoriasis, eczema, rickets, and jaundice. However, traditional UV light sources are bulky, fragile, and contain toxic mercury.
Until now, UV water disinfection has only been possible via large, expensive, centrally located disinfection hubs, leaving more than one-third of the world population without a viable UV disinfection solution.
Images credit: RayVio
The California-based RayVio’s Innovative UV LED solutions are making mobile disinfection possible, which will enable everyone to protect themselves, everywhere they go. RayVio is an advanced health and hygiene company that delivers clean water and environments. It helps protect billions from germs and creates new markets and revenue streams by enabling a new class of products.
RayVio recently announced that it has launched a new series of ultraviolet (UV) LEDs with the highest power output available from a small surface-mount device (SMD) footprint. This new series of UV LEDs are among the smallest commercially available at a width of 6.5 millimeters, enabling unparalleled flexibility to incorporate into a range of products from self-disinfecting water bottles to hospital surface cleaners, says RayVio press release.
The technology provides up to 40 milliwatts at 100 milliamperes continuous current operation in a single package, the most power available in that size on the market. With its wavelength in the range of 280 to 290 nanometers and its high power density, RayVio’s LEDs deactivate the DNA of bacteria, viruses, and other pathogens, thereby preventing disease.
Image credit: RayVio
RayVio’s patented technology, originally developed at Boston University by co-founders Dr. Yitao Liao and Dr. Theodore Moustakas, is intended to enable large-scale adoption of UV LEDs for industrial, digital health, and consumer sectors, with a variety of applications to benefit society.
Its unique, power-dense UV LED technology and materials are compact, instantly available, robust, mercury-free, energy-efficient, and long-lasting. Potential applications include improving the effectiveness and accessibility of disinfection techniques for water, food, air, and surfaces. The differentiated solution is of particular relevance to developing countries where access to clean drinking water is scarce, as well as for medical practitioners using UV devices to treat health ailments.
Doctors and scientists are discovering that there are a host of illnesses, ranging from vitamin D deficiency to Psoriasis and even Multiple Sclerosis that can be treated by exposure to the right dose and appropriate wavelength of UV light.
Its powerful and efficient UV LED technology can be integrated into a variety of applications, powering versatile on-demand solutions that give consumers control over health without chemicals or costly consumables.
It has recently raised $26 million in funding rounds led by two China-linked venture capital firms, IPV Capital and Tsing Capital. Participating current investors included DCM Ventures, Capricorn Investment Group, Applied Ventures, Augment Ventures, Tolero Ventures, and New Ground Ventures.
RayVio will exhibit its technology at the Association for Professionals in Infection Control and Epidemiology Annual Conference (APIC 2016) on June 11 through 13 in Charlotte, North Carolina, says RayVio press release.
